Ignite Creation Date:
2025-12-24 @ 3:40 PM
Ignite Modification Date:
2026-02-21 @ 12:52 PM
Study NCT ID:
NCT03826992
Status:
RECRUITING
Last Update Posted:
2025-05-14
First Post:
2019-01-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Sponsor:
Children's Hospital Medical Center, Cincinnati
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-12-27
Start Date Type:
ACTUAL
Primary Completion Date:
2027-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-09
First Submit QC Date:
None
Study First Post Date:
2019-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-12
Last Update Post Date:
2025-05-14
Last Update Post Date Type:
ACTUAL